- Leukemia
- Liver Cancer
- Lung Cancer
- Lung Cancer – Non-Small Cell
- Lung Cancer – Small Cell
- Lymphoma
- Melanoma
- Mesothelioma
- Miscellaneous
- Multiple Myeloma
- Myelodysplastic Syndrome
- Neuroblastoma
- Non-Hodgkin’s Lymphoma
- Aggressive/Intermediate Grade Non-Hodgkin’s Lymphoma
- Follicular Lymphoma
- Highly Aggressive/High Grade Non-Hodgkin’s Lymphoma
- Indolent/Low Grade Non-Hodgkin’s Lymphoma
- Mantle Cell Non-Hodgkin’s Lymphoma
- Recurrent Non-Hodgkin’s Lymphoma
- Screening/Prevention Non-Hodgkin’s Lymphoma
- T-Cell Non-Hodgkin’s Lymphoma
- Osteosarcoma
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Rectal Cancer
- Renal Cancer
- Retinoblastoma
- Sarcoma
- Skin Cancer
- Supportive Care
- Management and Prevention of Anemia Supportive Care
- Management and Prevention of Anorexia and Weight Loss Supportive Care
- Management and Prevention of Bone Complications Supportive Care
- Management and Prevention of Fatigue Supportive Care
- Management and Prevention of Mucositis Supportive Care
- Management and Prevention of Nausea and Vomiting Supportive Care
- Management and Prevention of Neutropenia Supportive Care
- Management and Prevention of Thrombocytopenia Supportive Care
- Testicular Cancer
- Throat Cancer
- Thyroid Cancer
- Uterine Cancer
- Vaginal Cancer
Cancer News
Keytruda Shows Promise in Treatment of Mesothelioma
(04/04/2017)
Keytruda (pembrolizumab), an antibody drug already used to treat other forms of cancer, can be effective in the treatment of the most common form of mesothelioma, according to a new study led by investigators from the Perelman School of Medicine at the University of Pennsylvania. The study, published in The Lancet Oncology, is the first …
Continue reading "Keytruda Shows Promise in Treatment of Mesothelioma"